Jiangzhong Pharmaceutical Co Ltd (600750) — Cash Flow-to-Debt Ratio
Jiangzhong Pharmaceutical Co Ltd (600750) has a Cash Flow-to-Debt Ratio of 0.00x as of December 2025, meaning its operating cash flow of CN¥-2.91 Million could theoretically repay 0% of its total liabilities (CN¥2.18 Billion) in one year. See Jiangzhong Pharmaceutical Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangzhong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Jiangzhong Pharmaceutical Co Ltd across 28 annual periods. Also explore Jiangzhong Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jiangzhong Pharmaceutical Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Jiangzhong Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see how much is Jiangzhong Pharmaceutical Co Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | CN¥970.87 Million | CN¥2.18 Billion | ▲ +15.5% |
| 2024 | 0.39x | CN¥786.25 Million | CN¥2.04 Billion | ▼ -33.9% |
| 2023 | 0.58x | CN¥1.04 Billion | CN¥1.77 Billion | ▲ +1.1% |
| 2022 | 0.58x | CN¥1.02 Billion | CN¥1.77 Billion | ▼ -10.8% |
| 2021 | 0.65x | CN¥917.04 Million | CN¥1.42 Billion | ▼ -42.1% |
| 2020 | 1.12x | CN¥752.50 Million | CN¥672.27 Million | ▲ +45.7% |
| 2019 | 0.77x | CN¥641.18 Million | CN¥834.84 Million | ▼ -11.0% |
| 2018 | 0.86x | CN¥486.25 Million | CN¥563.53 Million | ▲ +209.9% |
| 2017 | 0.28x | CN¥124.93 Million | CN¥448.74 Million | ▼ -82.1% |
| 2016 | 1.55x | CN¥698.05 Million | CN¥449.96 Million | ▼ -1.7% |
| 2015 | 1.58x | CN¥510.78 Million | CN¥323.74 Million | ▲ +427.9% |
| 2014 | 0.30x | CN¥356.80 Million | CN¥1.19 Billion | ▲ +129.4% |
| 2013 | 0.13x | CN¥111.92 Million | CN¥859.15 Million | ▼ -32.3% |
| 2012 | 0.19x | CN¥226.38 Million | CN¥1.18 Billion | ▼ -23.2% |
| 2011 | 0.25x | CN¥168.30 Million | CN¥671.11 Million | ▼ -18.0% |
| 2010 | 0.31x | CN¥222.29 Million | CN¥726.93 Million | ▼ -57.6% |
| 2009 | 0.72x | CN¥378.32 Million | CN¥524.73 Million | ▲ +65.4% |
| 2008 | 0.44x | CN¥268.87 Million | CN¥616.73 Million | ▲ +8.9% |
| 2007 | 0.40x | CN¥153.63 Million | CN¥383.89 Million | ▲ +312.9% |
| 2006 | 0.10x | CN¥55.24 Million | CN¥569.95 Million | ▼ -78.1% |
| 2005 | 0.44x | CN¥198.45 Million | CN¥449.20 Million | ▲ +743.4% |
| 2004 | 0.05x | CN¥26.28 Million | CN¥501.74 Million | ▼ -77.0% |
| 2003 | 0.23x | CN¥78.98 Million | CN¥347.14 Million | ▼ -60.3% |
| 2002 | 0.57x | CN¥94.90 Million | CN¥165.58 Million | ▲ +22.5% |
| 2001 | 0.47x | CN¥41.28 Million | CN¥88.23 Million | ▼ -37.5% |
| 2000 | 0.75x | CN¥121.77 Million | CN¥162.71 Million | ▲ +651.9% |
| 1999 | -0.14x | CN¥-21.89 Million | CN¥161.46 Million | ▼ -70.4% |
| 1998 | -0.08x | CN¥-11.42 Million | CN¥143.42 Million | — |